<DOC>
	<DOCNO>NCT01491802</DOCNO>
	<brief_summary>Preliminary information laboratory indicate even patient milder chronic obstructive pulmonary disease ( COPD ) significant physiological derangement become pronounced exercise , lead intolerable dyspnea low level ventilation health . This study explore pathophysiological mechanism dyspnea activity limitation GOLD stage II COPD determine sound physiological rationale use dual long-acting beta2-agonist ( LABA ) /long-acting muscarinic antagonist ( LAMA ) therapy ( GSK573719/ GW642444 Inhalation Powder ) versus LAMA alone ( GSK573719 ) treatment dyspnea exercise intolerance subpopulation . Objectives study determine : 1 ) neuromechanical uncouple respiratory system contribute exertional dyspnea milder COPD , 2 ) treatment LABA/LAMA improve dyspnea exercise endurance compare LAMA improve neuromechanical coupling . The investigator hypothesize : 1 ) dyspnea relate excessive dynamic lung hyperinflation , tidal volume restriction increase ratio central respiratory neural drive tidal volume displacement , measure neuromechanical uncoupling respiratory system , 2 ) LABA/LAMA improve dyspnea exercise endurance , explain partial reversal mechanical abnormality . The investigator conduct randomize , double-blind crossover study compare effect once-daily LABA/LAMA 4-weeks LAMA dyspnea , exercise endurance ventilatory mechanic GOLD stage II COPD .</brief_summary>
	<brief_title>Effect New Combination Bronchodilator Exercise GOLD Stage II Moderate COPD</brief_title>
	<detailed_description />
	<mesh_term>Muscarinic Antagonists</mesh_term>
	<criteria>Stable moderate COPD Postbronchodilator FEV1/FVC &lt; 0.7 50 % ≤FEV1 &lt; 80 % predict Baseline Dyspnea Index ≤ 9 MRC dyspnea scale &gt; 2 Cigarette smoke history least 20 packyears Presence significant disease COPD could contribute dyspnea exercise limitation Important contraindication clinical exercise test Use daytime oxygen History asthma</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>COPD</keyword>
	<keyword>Combination therapy</keyword>
	<keyword>Anticholinergic</keyword>
	<keyword>Beta2-agonist</keyword>
	<keyword>Exercise</keyword>
	<keyword>Dyspnea</keyword>
	<keyword>Respiratory mechanic</keyword>
</DOC>